Omnix Medical Launches New Horizon Europe PEPTAMR Infectious Disease Consortium

PartnershipOMN6Positive

AI Analysis

Summary

Omnix Medical secured approximately EUR 8M in Horizon Europe funding to launch the PEPTAMR Infectious Disease Consortium, advancing its lead program OMN6 toward Phase III clinical development.

Clinical Trial Data

Phase

Phase 3

Importance:5/10

Sentiment:

0.60

PartnershipHorizon EuropePEPTAMR ConsortiumInfectious DiseasePhase 3

Related Companies

$HZNP $MDCE

Read the original article

Published by GlobeNewswire Clinical Studies on July 13, 2026 8:00 AM

Read Original